Similar results have also been documented in Non-small-cell lung carcinoma (NSCLC) cell lines, where the downregulation of DUSP6 resulted in increased ERK5 activation and epithelial–mesenchymal transition (EMT), which was reversed by inducing DUSP6 re-activation [46]. Here, DUSP6 is linked to non-small cell lung carcinoma.